These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17274843)

  • 1. High road, low road? Choices and challenges on the pathway to a malaria vaccine.
    Richie T
    Parasitology; 2006; 133 Suppl():S113-44. PubMed ID: 17274843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and challenges for malaria vaccines.
    Richie TL; Saul A
    Nature; 2002 Feb; 415(6872):694-701. PubMed ID: 11832958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria vaccine development: recent progress towards a sporozoite vaccine.
    Good MF
    Semin Immunol; 1990 Sep; 2(5):361-7. PubMed ID: 2134019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing immune responses against Plasmodium for rational vaccine design.
    Douradinha B; Doolan DL
    Trends Parasitol; 2011 Jun; 27(6):274-83. PubMed ID: 21531627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced immunity to malaria parasites and the need for novel strategies.
    Good MF
    Trends Parasitol; 2005 Jan; 21(1):29-34. PubMed ID: 15639738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.
    Taylor-Robinson AW
    Expert Rev Vaccines; 2002 Oct; 1(3):317-40. PubMed ID: 12901572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards the development of malaria vaccines.
    Malkin E; Dubovsky F; Moree M
    Trends Parasitol; 2006 Jul; 22(7):292-5. PubMed ID: 16707275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against malaria with live parasites.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Expert Rev Vaccines; 2006 Aug; 5(4):473-81. PubMed ID: 16989628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria vaccines: are we getting closer?
    Epstein JE; Giersing B; Mullen G; Moorthy V; Richie TL
    Curr Opin Mol Ther; 2007 Feb; 9(1):12-24. PubMed ID: 17330398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asexual blood-stage malaria vaccine development: facing the challenges.
    Genton B; Reed ZH
    Curr Opin Infect Dis; 2007 Oct; 20(5):467-75. PubMed ID: 17762779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in malaria control in sub-Saharan Africa: the vaccine perspective.
    Lusingu JP; Von Seidlein L
    Tanzan J Health Res; 2008 Oct; 10(4):253-66. PubMed ID: 19402588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity to pre-erythrocytic stage malaria.
    Schwenk RJ; Richie TL
    Trends Parasitol; 2011 Jul; 27(7):306-14. PubMed ID: 21435951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative immunobiology of Plasmodium: model systems and new technologies in malaria vaccine research.
    Mitchell GH
    Prog Vet Microbiol Immunol; 1987; 3():112-38. PubMed ID: 3078831
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria vaccines.
    Gordon DM
    Infect Dis Clin North Am; 1990 Jun; 4(2):299-313. PubMed ID: 2189001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspectives and challenges of malaria vaccine. Why we must do more].
    Leroy O
    Bull Acad Natl Med; 2007 Oct; 191(7):1249-59; discussion 1259-60. PubMed ID: 18447047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.